Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
...
Next
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jun 30, 2023 8:31am
RE:RE:RE:RE:RE:Here's the thing
Yes it is a good post in my view as well.
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Jun 30, 2023 7:56am
RE:Ceo
Name a wildly successful company with a part time CEO? Science and compounds are solid - CEO (part time) is as solid as jello. His ego and stranglehold on the company are keeping him there - I
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Post by
SleepyHoward
on Jun 30, 2023 4:19am
Ceo
Parttime is Parttime. 99% hospital, 1 % sirona. Result is the share prize
(10)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Jun 30, 2023 2:03am
RE:RE:RE:RE:Here's the thing
What a fantastic comment!! Thanks for that. So true. Maybe Howard can spend 5 minutes from his valuable time to read this post. Cheers.
(11)
•••
Transperance
X
View Profile
View Bullboard History
Comment by
Transperance
on Jun 29, 2023 10:21am
RE:RE:RE:Here's the thing
Secrecy or transparency? It would be nice if Sirona was to be acquired with a 700 or 800% bid premium like Sigilon, but is it likely? No shareholder can make such an assessment today. We have
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jun 29, 2023 9:23am
RE:RE:Here's the thing
Link below: This is probably what will happen to Sirona, if we are to see those kinds of valuations. There is no way he or Geraldine or Chris will ever be able to exit stage right with their holdings
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Jun 29, 2023 2:30am
RE:Here's the thing
We need real numbers in order to deem the value of this company. For the moment the share trades between 13-14 cents, but if we had more information the range could be 40-50 or 120-130. Nevertheless,
...more
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 28, 2023 2:53pm
RE:New Press Release - Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEB
zzzzzzzzzzzzzzzzzz
(101)
•••
biorun
X
View Profile
View Bullboard History
Post by
biorun
on Jun 28, 2023 1:37pm
Here's the thing
None, and I mean none of these updates mean a darn thing to the market UNTIL we see either $ in financial statements to signal a milestone payment by AbbVie, an announcement that they are market
...more
(10)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Jun 28, 2023 12:42pm
RE:GREAT PRESS RELEASE, BUT ANOTHER DANGLING CARROT AND NO CASH
As long as Howard and Chris are on top of this company, these dangling carrots will be our normal routine. Thanks again to Geraldine for the hard work on that Antiviral compound. European enthuisim
...more
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Jun 28, 2023 12:38pm
RE:GREAT PRESS RELEASE, BUT ANOTHER DANGLING CARROT AND NO CASH
Zero shares traded on this news kind of says if all! How about the animal contract Howard has been saying is "almost" signed for years now? How about hitting a milestone payment with
...more
(80)
•••
bealert
X
View Profile
View Bullboard History
Post by
bealert
on Jun 28, 2023 12:04pm
GREAT PRESS RELEASE, BUT ANOTHER DANGLING CARROT AND NO CASH
One of these decades Sirona may eventually get something going that we can take to the bank. In the meantime we live in secrecy with non-disclosure reigning supreme, and no doubt dwindling cash in the
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 28, 2023 9:00am
New Press Release - Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEB
VANCOUVER, British Columbia, June 28, 2023 (GLOBE NEWSWIRE) -- June 28, 2023 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) ("Sirona") is excited to announce the development of a promising new set of potential antiviral compounds which will undergo testing at the renowned...
read article.
(10)
•••
BradlTheGerman
X
View Profile
View Bullboard History
Comment by
BradlTheGerman
on Jun 27, 2023 10:01am
RE:Novartis and the (still?) non-existent SGLT2 inhibitor?!
370 / 3000 bersetzter Text The German imagination knows no bounds. If TFC-039 were an important
...more
Prev
...
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >